Phase II trial of Eribulin/S-1 combination therapy for advanced/recurrent breast cancer

被引：0
|
作者：
Iwasa, Tsutomu [1 ]
Komoike, Yoshifumi [7 ]
Tsurutani, Junji [1 ]
Nakagawa, Kazuhiko [1 ]
Mizuno, Yutaka [2 ]
Matsunami, Nobuki [3 ]
Yamamura, Jun [4 ]
Otani, Shoichiro [5 ]
Kojima, Yasuyuki [6 ]
Watanabe, Satomi [1 ]
机构：
[1] Kinki Univ, Fac Med, Dept Med Oncol, Higashiosaka, Osaka 577, Japan
[2] Yokkaichi Municipal Hosp, Dept Breast Surg, Yokaichi, Japan
[3] Osaka Rosai Hosp, Dept Breast Surg, Sakai, Osaka, Japan
[4] Sakai City Med Ctr, Dept Breast & Endocrine Surg, Sakai, Osaka, Japan
[5] Hiroshima City Hiroshima Citizens Hosp, Dept Breast Surg, Hiroshima, Japan
[6] St Marianna Univ, Sch Med, Dept Breast & Endocrine Surg, Kawasaki, Kanagawa, Japan
[7] Kinki Univ, Fac Med, Dept Breast & Endocrine Surg, Higashiosaka, Osaka 577, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O1-15-2
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase II study of combination therapy with irinotecan and S-1 (IRIS) in patients with advanced colorectal cancer
    Shiozawa, Manabu
    Akaike, Makoto
    Sugano, Nobuhiro
    Tsuchida, Kazuhito
    Yamamoto, Naoto
    Morinaga, Soichiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (05) : 987 - 992
  • [32] Phase II trial report of the new neoadjuvant chemotherapy with S-1 and docetaxel for advanced breast cancer
    Okazaki, K.
    Kira, M.
    Yamai, H.
    Nakagawa, Y.
    Nagao, T.
    Kenzaki, K.
    Bando, Y.
    Morimoto, T.
    Kondo, K.
    Tangoku, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [33] Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age
    Zang, Dae Young
    Yang, Dae Hyun
    Lee, Hae Wan
    Hwang, Se Won
    Song, Hun Ho
    Jung, Joo Young
    Kwon, Jung Hye
    Kim, Hyo Jung
    Kim, Jung Han
    Park, Sa Rah
    Kim, Min-Jeong
    Jang, Kyung Mi
    Park, Choong Kee
    Kim, Jong Hyeok
    Lee, Bong Hwa
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (03) : 509 - 516
  • [34] Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age
    Dae Young Zang
    Dae Hyun Yang
    Hae Wan Lee
    Se Won Hwang
    Hun Ho Song
    Joo Young Jung
    Jung Hye Kwon
    Hyo Jung Kim
    Jung Han Kim
    Sa Rah Park
    Min-Jeong Kim
    Kyung Mi Jang
    Choong Kee Park
    Jong Hyeok Kim
    Bong Hwa Lee
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 509 - 516
  • [35] A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer
    Ozge Gumusay
    Laura A. Huppert
    Mark Jesus M. Magbanua
    Chiara A. Wabl
    Michael Assefa
    Amy Jo Chien
    Michelle E. Melisko
    Melanie C. Majure
    Mark Moasser
    John Park
    Hope S. Rugo
    Breast Cancer Research and Treatment, 2024, 203 : 197 - 204
  • [36] A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer
    Gumusay, Ozge
    Huppert, Laura A.
    Magbanua, Mark Jesus M.
    Wabl, Chiara A.
    Assefa, Michael
    Chien, Amy Jo
    Melisko, Michelle E.
    Majure, Melanie C.
    Moasser, Mark
    Park, John
    Rugo, Hope S.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (02) : 197 - 204
  • [37] A Multicenter Phase II Trial of S-1 With Concurrent Radiation Therapy for Locally Advanced Pancreatic Cancer
    Ikeda, Masafumi
    Ioka, Tatsuya
    Ito, Yoshinori
    Yonemoto, Naohiro
    Nagase, Michitaka
    Yamao, Kenji
    Miyakawa, Hiroyuki
    Ishii, Hiroshi
    Furuse, Junji
    Sato, Keiko
    Sato, Tosiya
    Okusaka, Takuji
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (01): : 163 - 169
  • [38] Phase II trial of a combination chemotherapy of CPT-11 and S-1 in patients with advanced/recurrent colorectal cancer (OGSG-0405)
    Tomita, N.
    Okamura, S.
    Nakata, K.
    Murata, K.
    Tokunaga, Y.
    Umeki, M.
    Takiuchi, H.
    Furukawa, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
    Song, Hunho
    Han, Boram
    Park, Choong Kee
    Kim, Jong Hyeok
    Jeon, Jang Yong
    Kim, In-Gyu
    Kim, Hyo Jung
    Jung, Joo Young
    Kim, Jung Han
    Kwon, Jung Hye
    Jang, Geundoo
    Kim, Ho Young
    Kim, Hyeong Su
    Choi, Dae Ro
    Zang, Dae Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (04) : 845 - 852
  • [40] Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer
    Hunho Song
    Boram Han
    Choong Kee Park
    Jong Hyeok Kim
    Jang Yong Jeon
    In-Gyu Kim
    Hyo Jung Kim
    Joo Young Jung
    Jung Han Kim
    Jung Hye Kwon
    Geundoo Jang
    Ho Young Kim
    Hyeong Su Kim
    Dae Ro Choi
    Dae Young Zang
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 845 - 852
12345